BRIEF-Knight therapeutics says Profounda inc launches Impavido in the U.S.

Tue Mar 22, 2016 8:40am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

March 22 (Reuters) - Knight Therapeutics Inc

* Says U.S. Commercialization partner, profounda inc has launched Impavido (miltefosine) in united states Source text for Eikon: Further company coverage: